A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320

Sperduto, Paul W., Wang, Meihua, Robins, H. Ian, Schell, Michael C., Werner-Wasik, Maria, Komaki, Ritsuko, Souhami, Luis, Buyyounouski, Mark K. +7 more·2013·International Journal of Radiation Oncology*Biology*Physics
DOI 10.1016/j.ijrobp.2012.11.042

Cited by (273)

Items 101–200 of 273

  1. The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation
    Willem J. A. Witlox, Bram L. T. Ramaekers, Jaap D. Zindler, Daniëlle B. P. Eekers, Judith van Loon, Lizza E.L. Hendriks, Anne‐Marie C. Dingemans, Dirk De Ruysscher · 2018 · Frontiers in Oncology
  2. Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
    Paola Anna Jablonska, Joaquim Bosch‐Barrera, Diego Serrano, Manuel Valiente, Alfonso Calvo, Javier Aristu · 2021 · Cancers
  3. Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis
    Hong Qin, Feng Pan, Jianjun Li, Xiaoli Zhang, Houjie Liang, Zhihua Ruan · 2014 · PLoS ONE
  4. Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies
    Leila T. Tchelebi, Emma Batchelder, Ming Wang, Eric J. Lehrer, Joseph J. Drabick, Navesh K. Sharma, Mitchell X. Machtay, Daniel Michael Trifiletti, Nicholas George Zaorsky · 2021 · JNCI Cancer Spectrum
  5. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer
    Kyung Rae Cho, Min Ho Lee, Doo‐Sik Kong, Ho Jun Seol, Do‐Hyun Nam, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Sung Tae Kim et al. · 2015 · Journal of Neuro-Oncology
  6. A Neuro-oncologist’s Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer
    Tresa Michelle McGranahan, Seema Nagpal · 2017 · Current Treatment Options in Oncology
  7. Clinical outcomes of non–small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone
    Ammoren E. Dohm, Joseph D. Tang, Matthew N. Mills, Casey L. Liveringhouse, María L. Sandoval, Bradford A. Perez, Timothy J. Robinson, Ben Creelan, Jhanelle E. Gray, Arnold B. Etame et al. · 2022 · Journal of neurosurgery
  8. Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
    Felipe Couñago, Aurora Rodríguez Pérez, Patricia Calvo, Javier Luna, Jose Luis Monroy, Begoña Taboada, V. Díaz Díaz, N. Rodríguez de Dios · 2016 · Clinical & Translational Oncology
  9. The Current Role of Whole Brain Radiation Therapy in Non–Small Cell Lung Cancer Patients
    Gokoulakrichenane Loganadane, Lizza E.L. Hendriks, Cecile Le Pechoux, Antonin Lévy · 2017 · Journal of Thoracic Oncology
  10. Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer
    Nam Q. Bui, Brian D. Woodward, Anna Johnson, Hatim Husain · 2016 · Current Treatment Options in Oncology
  11. WBRT for brain metastases from non-small cell lung cancer: for whom and when?—Contemporary point of view
    Beata Sas-Korczyńska, Monika Rucińska · 2021 · Journal of Thoracic Disease
  12. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer
    Georgios Tsakonas, Vasisht R. Tadigotla, Sudipto K. Chakrabortty, Giuseppe Stragliotto, Dalin Chan, Rolf Lewensohn, Wei Yu, Johan Skog, Per Hydbring, Simon Ekman · 2023 · Lung Cancer
  13. Concurrent versus sequential whole brain radiotherapy and TKI in EGFR-mutated NSCLC patients with brain metastasis
    Hualin Chen, Aibing Wu, Hua Tao, Donghong Yang, Yiping Luo, Shujun Li, Zhixiong Yang, Ming Chen · 2018 · Medicine
  14. Targeted Therapies for Brain Metastases
    Ajay Niranjan, L. Dade Lunsford, Manmeet Singh Ahluwalia · 2019 · Progress in neurological surgery
  15. Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches
    Mario Levis, Alessio Gastino, Greta De Giorgi, Cristina Mantovani, Paolo Bironzo, Luca Mangherini, Alessia Andrea Ricci, Umberto Ricardi, Paola Cassoni, Luca Bertero · 2023 · Cancers
  16. Targeted and Immunotherapeutic Approaches in Brain Metastases
    Manmeet Singh Ahluwalia, Frank Winkler · 2015 · American Society of Clinical Oncology Educational Book
  17. Management of solitary and multiple brain metastases from breast cancer
    Addison B. Willett, John Ben Wilkinson, Chirag Shah, Minesh P. Mehta · 2015 · Indian Journal of Medical and Paediatric Oncology
  18. Targeting Molecular Pathways in Intracranial Metastatic Disease
    Vyshak Alva Venur, Justine Vanessa Cohen, Priscilla Kaliopi Brastianos · 2019 · Frontiers in Oncology
  19. Selection of prescription isodose line for brain metastases treated with volumetric modulated arc radiotherapy
    Yuan Xu, Pan Ma, Yingjie Xu, Jianrong Dai · 2019 · Journal of Applied Clinical Medical Physics
  20. RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases – results and lessons learnt
    Avinash Gupta, Corran Roberts, Finn Tysoe, Matthew Goff, Jenny Penelope Nobes, J. Lester, Ernie Marshall, Carie Corner, Virginia Wolstenholme, Charles Gerald Kelly et al. · 2016 · British Journal of Cancer
  21. Association d’une chimiothérapie ou d’un traitement ciblé à une irradiation stéréotaxique : état des lieux et recommandations préliminaires
    Juliette Thariat, Youlia Kirova, Gerard Alain Milano, F. Mornex · 2014 · Cancer/Radiothérapie
  22. The evolving clinical management of cerebral metastases
    Rohitashwa Sinha, W. Sage, C. Watts · 2016 · European Journal of Surgical Oncology
  23. Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2‐positive breast cancer
    Peng Yuan, Songlin Gao · 2017 · Chronic Diseases and Translational Medicine
  24. Metastasis to the Central Nervous System
    Adrienne Ann Boire · 2020 · CONTINUUM Lifelong Learning in Neurology
  25. Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
    Min Ho Lee, Kyung Rae Cho, Jung Won Choi, Doo‐Sik Kong, Ho Jun Seol, Do‐Hyun Nam, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn et al. · 2020 · Journal of Korean Neurosurgical Society
  26. Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update
    Çağatay Arslan, Ömer Dızdar, Kadri Altundağ · 2014 · Expert Opinion on Pharmacotherapy
  27. Strategies to target drugs to gliomas and CNS metastases of solid tumors
    Bojana Milojkovic Kerklaan, Olaf van Tellingen, Alwin D. R. Huitema, Jos H. Beijnen, Willem J. Boogerd, Jan H.M. Schellens, Dieta Brandsma · 2015 · Journal of Neurology
  28. Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches
    Rimas Vincas Lukas, Maciej S. Lesniak, Ravi Salgia · 2014 · CNS Oncology
  29. A hybrid volumetric dose verification method for single‐isocenter multiple‐target cranial SRS
    Saeed Ahmed, Jeffrey M. Kapatoes, Geoffrey G. Zhang, Eduardo G. Moros, Vladimir M. Feygelman · 2018 · Journal of Applied Clinical Medical Physics
  30. Radiotherapy of Non-Small-Cell Lung Cancer in the Era of EGFR Gene Mutations and EGF Receptor Tyrosine Kinase Inhibitors
    Ilaria Moschini, Cristina Dell’Anna, Pier Luigi Losardo, Paola Bordi, Nunziata D’Abbiero, Marcello Tiseo · 2015 · Future Oncology
  31. Impact of systemic treatment on survival after whole brain radiotherapy in patients with brain metastases
    Carsten Nieder, Kirsten Marienhagen, Astrid Dalhaug, Gro Aandahl, Ellinor Christin Haukland, Adam Pawinski · 2014 · Medical Oncology
  32. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan
    Ching‐Heng Lin, Kuo-Hsuan Hsu, Shih‐Ni Chang, Hsi‐Kai Tsou, Jason P. Sheehan, Meei‐Ling Sheu, Hung-Chuan Pan · 2015 · Radiation Oncology
  33. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery
    Samuel Minkee Shin, Benjamin Thomas Cooper, Abraham Chachoua, James Thomas Butler, Bernadine R. Donahue, Joshua Seth Silverman, Douglas S Kondziolka · 2015 · Journal of Neuro-Oncology
  34. Emerging Opportunities for the Combination of Molecularly Targeted Drugs with Radiotherapy
    Emma J Searle, Tim Illidge, Ian James Stratford · 2014 · Clinical Oncology
  35. Combination of Radiotherapy and Targeted Agents in Brain Metastasis: An Update
    Zarmeneh Aly, David M. Peereboom · 2016 · Current Treatment Options in Neurology
  36. Intracranial Metastatic Disease: Present Challenges, Future Opportunities
    Alyssa Y. Li, Karolina Gaebe, Katarzyna Joanna Jerzak, Parneet Kaur Cheema, Arjun Sahgal, Sunit Das · 2022 · Frontiers in Oncology
  37. A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases
    Kyle O. Arneson, Joshua K. Mondschein, Mark J. Stavas, Anthony J. Cmelak, Albert A. Attia, Leora Horn, Kenneth J. Niermann, Igor J. Puzanov, A. Bapsi Chakravarthy, Fen Xia · 2017 · Journal of Neuro-Oncology
  38. Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
    Stefano Frega, Laura Bonanno, Valentina Guarneri, PierFranco Conte, Giulia Pasello · 2018 · Critical Reviews in Oncology/Hematology
  39. Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases
    Santiago Ponce, Jordi Bruna, Óscar Juan, Rafael López Castro, Alejandro Navarro, Ana Laura Ortega Granados, Javier Puente, Eugènia Verger, Adela Gejo Bartolomé, Ernest Nadal · 2019 · Critical Reviews in Oncology/Hematology
  40. Enhanced efficacy of AZD3759 and radiation on brain metastasis from EGFR mutant non‐small cell lung cancer
    Xue Li, Yingchun Wang, Jia Wang, Tianwei Zhang, Zheng Li, Zhenfan Yang, Ligang Xing, Jinming Yu · 2018 · International Journal of Cancer
  41. Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy
    Akimasa Sekine, Hiroaki Satoh · 2017 · Medical Oncology
  42. Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
    Qian Zhao, Qin Qin, Jinglong Sun, Dan Han, Zhongtang Wang, Junjie Teng, Baosheng Li · 2016 · PLoS ONE
  43. The impact of systemic precision medicine and immunotherapy treatments on brain metastases
    Rowland H. Han, Gavin P. Dunn, Milan G. Chheda, Albert H. Kim · 2019 · Oncotarget
  44. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments
    Edgar Selzer, Gabriela Verena Kornek · 2013 · Expert Review of Clinical Pharmacology
  45. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort
    Xiaobing Li, De Pei Wu, Jing Ping Tang, Yuebing Wu · 2024 · Journal of Cancer Research and Clinical Oncology
  46. Efficacy of RetroNectin-Activated Cytokine-Induced Killer Cell Therapy in Metastatic Brain Tumor Patients
    Wei Li, Yaomei Wang, Lingdi Zhao, Linping Xu, Yong Zhang, Ling Mai, Quanli Gao · 2015 · Oncology Research and Treatment
  47. Modern Management of Central Nervous System Metastases in the Era of Targeted Therapy and Immune Oncology
    Priscilla Kaliopi Brastianos, Michael A. Davies, Kim Allyson Margolin, Helena Alexandra Yu · 2019 · American Society of Clinical Oncology Educational Book
  48. Systemic Treatment of Brain Metastases
    Saiama Naheed Waqar, Daniel Morgensztern, Ramaswamy Govindan · 2016 · Hematology/Oncology Clinics of North America
  49. Systemic Therapies in the Treatment of Non-Small-Cell Lung Cancer Brain Metastases
    Rimas Vincas Lukas, Priya Kumthekar, Syeda Rizvi, Ravi Salgia · 2016 · Future Oncology
  50. The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival
    Anders Wilder Erickson, Sunit Das · 2019 · Frontiers in Oncology
  51. Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis
    Georgios Tsakonas, Simon Ekman, Andreas Koulouris, Helen Adderley, Christoph Jakob Ackermann, Raffaele Califano · 2023 · International Journal of Cancer
  52. The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer
    Shyam Kumar Tanguturi, Laura Elizabeth Warren · 2019 · Current Oncology Reports
  53. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress
    Lei Liu, Wanqi Chen, Ruopeng Zhang, Yuekun Wang, Penghao Liu, Xin Lian, Fuquan Zhang, Yu Wang, Wenbin Ma · 2020 · Cancer Biology and Medicine
  54. Traitement systémique des métastases cérébrales de cancer bronchique
    Fabrice Barlési, Jean‐Philippe Spano, Alexis Benjamin Cortot, A.F. Carpentier, G. Robinet, Benjamin Besse · 2015 · Cancer/Radiothérapie
  55. PP03. HUMAN ENDOGENOUS RETROVIRUS TYPE K (HERVK) PROTEINS ARE OVEREXPRESSED AND RELEASED FROM HUMAN PRIMARY SCHWANNOMA CELLS CONTRIBUTING TO TUMOUR DEVELOPMENT VIA ERK, AKT, FAK PATHWAYS ACTIVATION AND P53 DOWNREGULATION
    Sylwia Ammoun, Mr Emmanuel Maze, Shona Reeves, David A. Hilton, Emanuela Ercolano, Prof Oliver Hamemann, Robert D. Belshaw · 2017 · Neuro-Oncology
  56. Contemporary Management of 1–4 Brain Metastases
    Sarah M. C. Sittenfeld, John H. Suh, Erin Sennett Murphy, Jennifer S. Yu, Samuel T. Chao · 2018 · Frontiers in Oncology
  57. In Regard to Sperduto et al
    H. Ian Robins, Anne O’Neill, Minesh P. Mehta, Stuart A. Grossman · 2013 · International Journal of Radiation Oncology*Biology*Physics
  58. Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer
    Seema Nagpal, Michael T. Milano, Veronica Chiang, Scott G. Soltys, Alexandria L. Brackett, Lia Moriguchi Halasz, Amit Kumar Garg, Arjun Sahgal, Manmeet Singh Ahluwalia, Martin C. Tom et al. · 2024 · Neuro-Oncology
  59. Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System
    Mohini Singh, David Bakhshinyan, Chitra Venugopal, Sheila Kumari Singh · 2017 · Frontiers in Oncology
  60. The Future of Targeted Therapies for Brain Metastases
    Anna Sophie Berghoff, Matthias Preusser · 2015 · Future Oncology
  61. Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
    Jianguo Han, Ming Qiu, Li Su, Chong Wu, Si Yuan Cheng, Zhijun Zhao, Danxia Li, Menghui Wang, Wei Tao, Shiwei Du · 2021 · Thoracic Cancer
  62. Novel therapeutic agents in the management of brain metastases
    Vyshak Alva Venur, Manmeet Singh Ahluwalia · 2017 · Current Opinion in Oncology
  63. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases
    Alexander F. C. Hulsbergen, Nayan Lamba, An Claes, Vasileios K. Kavouridis, NU Lin, Timothy Richard Smith, Joost J.C. Verhoeff, Marike L. D. Broekman · 2019 · World Neurosurgery
  64. Current chemotherapeutic regimens for brain metastases treatment
    Joo Yeon Nam, Barbara Jane O'Brien · 2017 · Clinical & Experimental Metastasis
  65. A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases
    Nan Bi, Yuchao Ma, Jianping Xiao, Hongmei Zhang, Yingjie Xu, Yuan Tian, Junling Li, Ye Zhang, Qingfeng Liu, Kai Wang et al. · 2019 · The Oncologist
  66. Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases
    Yutaro Koide, Naoya Nagai, Risei Miyauchi, Tomoki Kitagawa, Takahiro Aoyama, Hidetoshi Shimizu, Shingo Hashimoto, Hiroyuki Tachibana, Takeshi Kodaira · 2023 · Japanese Journal of Clinical Oncology
  67. Current progress and outcomes of clinical trials on using epidermal growth factor receptor‐tyrosine kinase inhibitor therapy in non‐small cell lung cancer patients with brain metastases
    Ling‐Ling Kong, Linlin Wang, Ligang Xing, Jinming Yu · 2017 · Chronic Diseases and Translational Medicine
  68. Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system
    Xuyao Yu, Yuwen Wang, Zhiyong Yuan, Hui Ming Yu, Yongchun Song, Lujun Zhao, Ping Wang · 2020 · BMC Cancer
  69. Towards updated understanding of brain metastasis.
    Shuncong Wang, Yuanbo Feng, Lei Chen, Jie Yu, Chantal Van Ongeval, Guy M Bormans, Yue Li, Yicheng Ni · 2022 · PubMed Central
  70. The Globalization of Cooperative Groups
    Manuel Valdivieso, Benjamin William Corn, Janet Ellen Dancey, Donald Lawrence Wickerham, Laura Elise Horvath, Edith A. Perez, Alison May Urton, Walter M. Cronin, Erica Field, Evonne Lackey et al. · 2015 · Seminars in Oncology
  71. Systemic treatment of non-small cell lung cancer brain metastases
    Ida Cedrych, Maksymilian Kruczała, Tomasz Walasek, Jerzy Jakubowicz, Paweł Blecharz, Marian Reinfuss · 2016 · Współczesna Onkologia
  72. Management evaluation of metastasis in the brain (MEMBRAIN)—a United Kingdom and Ireland prospective, multicenter observational study
    Josephine Jung, Jignesh K. Tailor, Emma Dalton, Laurence Johann Glancz, Joy Roach, Rasheed Zakaria, Simon Lammy, Ajai Chari, Karol P. Budohoski, Laurent J. Livermore et al. · 2019 · Neuro-Oncology Practice
  73. Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy
    Koken Ameku, Mariko Higa · 2020 · Case Reports in Oncological Medicine
  74. Brain metastases and treatment: multiplying cognitive toxicities
    Elise F. Nassif, Alexandre Arsene-Henry, Youlia Kirova · 2019 · Expert Review of Anticancer Therapy
  75. Stereotactic radiosurgery in the management of non–small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry
    Giorgos D. Michalopoulos, Konstantinos Katsos, Inga Siiner Grills, Ronald E. Warnick, James McInerney, Albert A. Attia, Robert D Timmerman, Eric Lin Chang, David William Andrews, Anthony L. D’Ambrosio et al. · 2023 · Journal of neurosurgery
  76. Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma
    Yuankai Shi, Jianping Xu, Xiaoyan Liu, Sheng Yang, Xiangru Zhang · 2016 · OncoTargets and Therapy
  77. Evaluation on efficacy and safety of the addition of X-knife therapy to gefitinib in NSCLC patients with symptomatic brain metastases
    Linbo Cai, Xiaoguang Qiu, Haihong Yang, Mingyao Lai, Changguo Shan, Weiping Hong, Juan Li, Longhui Luo, Ping Zhang, Lichao Wang · 2016 · Oncotarget
  78. Brain Metastasis as Complication of Systemic Cancers
    Riccardo Soffietti, Federica Franchino, Roberta Rudà · 2017 · Springer eBooks
  79. The Red Journal's Top Downloads of 2013
    Anthony Laurence Zietman · 2014 · International Journal of Radiation Oncology*Biology*Physics
  80. Comparative Efficacy of Treatments for Brain Metastases from Non–Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-Analysis
    Karanbir Brar, Shervin Taslimi, Yosef Ellenbogen, Jiawen Deng, Winston Hou, Fábio Ynoe de Moraes, Michael Glantz, Brad E. Zacharia, Aaron C. Tan, Manmeet Singh Ahluwalia et al. · 2021 · World Neurosurgery
  81. Systemic Therapy after Radiotherapy Significantly Reduces the Risk of Mortality of Patients with 1–3 Brain Metastases
    Bo Li, Zhao-Xia Dai, Yidong Chen, Yanwei Liu, Shuai Liu, Xue-Nan Gu, Xiaoguang Qiu · 2017 · Chinese Medical Journal
  82. Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide
    Yi Yang, Yu Pu, Nan Dai, Dong Wang, Mingfang Xu · 2020 · Medicine
  83. Oral Targeted Therapies and Central Nervous System (CNS) Metastases
    Michael P. Gabay, Scott M Wirth, Joan M Stachnik, Colleen Westendorf-Overley, Katie E Long, Linda R. Bressler, John Lee Villano · 2015 · CNS Drugs
  84. Stereotactic body radiation therapy for liver metastases in oligometastatic disease
    Nicolas Jaksic, A. Modesto, Nicolas Meillan, A. Bordron, Morgan Michalet, Olivier Riou, A. Lisbona, F. Huguet · 2023 · Cancer/Radiothérapie
  85. Place de l’association radiothérapie encéphalique et thérapies systémiques dans le traitement des métastases cérébrales d’un cancer du sein
    Kim I. Cao, Youlia Kirova · 2014 · Cancer/Radiothérapie
  86. High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC
    Georgios Tsakonas, Alfonso Martín-Bernabé, Konstantinos Rounis, Pablo Moreno-Ruiz, Johan Botling, Luigi De Petris, Antti Ylipää, Artur Mezheyeuski, Patrick Micke, Arne Östman et al. · 2021 · Cancers
  87. Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
    Rovel J. Colaco, Henry Soo-Min Park, Maxwell S. H. Laurans, Veronica Chiang, James B. Yu, Zain Ali Husain · 2016 · Cureus
  88. Quality of life and efficacy of temozolomide combined with whole-brain radiotherapy in patients with brain metastases from non-small-cell lung cancer
    Yajuan Lv, Jiandong Zhang, Zhen Liu, Ning Liang, Yuan Tian · 2018 · Molecular and Clinical Oncology
  89. Curing Metastatic Disease With Ablative Radiation Therapy: Separating Truth From Wish
    Sophia C. Kamran, Anthony Laurence Zietman · 2020 · International Journal of Radiation Oncology*Biology*Physics
  90. Icotinib as initial treatment in lung adenocarcinoma patients with brain metastases
    Jian‐ping Xu, Xiao‐yan Liu, Sheng Yang, Chang‐gong Zhang, Lin Wang, Yuankai Shi · 2016 · Thoracic Cancer
  91. Brain Metastasis from Solid Tumors
    Sami I. Bashour, William N. William, Sapna Pradyuman Patel, Ganesh Rao, Eric A. Strom, Mary Frances McAleer, Nandita Guha‐Thakurta, Charles A. Conrad, Nuhad K. Ibrahim · 2015 · Elsevier eBooks
  92. Should Erlotinib Be Coadministered With Whole-Brain Radiotherapy in Patients With Brain Metastases and Non–Small-Cell Lung Cancer?
    Marc Charles Chamberlain · 2013 · Journal of Clinical Oncology
  93. ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors
    Evert S.M. van Aken, Sean Michael O'Cathail, A.K. Gandhi, Johan Bussink, L. Castelo-Branco, Jesper Grau Eriksen, Guillem Argilés, Crispin T. Hiley, Victoria G. Atkinson, Joanna Kaźmierska et al. · 2026 · ESMO Open
  94. The Changing Paradigm of Treatment for Non-Small Cell Lung Cancer Intracranial Metastases
    Gregory Albert Azzam, Eric A. Mellon, Stuart E. Samuels, Raphael L. Yechieli · 2018 · Current Pulmonology Reports
  95. Stereotactic radiosurgery in the era of novel systemic therapy for lung cancer brain metastases
    Sarah Elizabeth Mudra, Shruti Bhandari, Prashant Tripathi, Neal Dunlap, Goetz Hans Kloecker · 2019 · Journal of Cancer Metastasis and Treatment
  96. Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
    Chengkai Zhang, Wenjianlong Zhou, Dainan Zhang, Shunchang Ma, Xi Wang, Wang Jia, Xiudong Guan, Ke Qian · 2023 · Open Medicine
  97. Survival was Significantly Better with Surgical/Medical/Radiation Co-interventions in a Single-Institution Practice Audit of Frameless Stereotactic Radiosurgery
    Amandeep Singh Taggar, Joanna MacKenzie, Haocheng Li, Harold Lau, Gerald Lim, Robert Nordal, Alana Hudson, Rao Muhammad Afzal Khan, David P. Spencer, Jon-Paul Voroney · 2016 · Cureus
  98. The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery
    Min Ho Lee, Doo‐Sik Kong, Ho Jun Seol, Do‐Hyun Nam, Jung-Il Lee · 2016 · Journal of Korean Neurosurgical Society
  99. Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer
    Heng Lin, Shuimei Luo, Lina Li, Sijing Zhou, Ruifen Shen, Haitao Yang, Yu‐Peng Wu, Xianhe Xie · 2017 · Molecular and Clinical Oncology
  100. Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer
    Anna Patla, Tomasz Walasek, Jerzy Jakubowicz, Paweł Blecharz, Jerzy Władysław Mituś, Anna Mucha-Małecka, Marian Reinfuss · 2016 · Współczesna Onkologia